Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek M Mekhail

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gynecologic Oncology|January 29, 2002
Acanthosis nigricans with endometrial carcinoma: case report and review of the literatureTarek M Mekhail, Maurie Markman
Expert Opinion on Pharmacotherapy|May 31, 2002
Paclitaxel in cancer therapyTarek M Mekhail, Maurie Markman
Current Oncology Reports|March 2, 2006
Phenoxodiol: isoflavone analog with antineoplastic activityToni K Choueiri, Robert Wesolowski, Tarek M Mekhail
Molecular Cancer Therapeutics|August 5, 2010
Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expressionWioleta Luszczek, Venugopalan Cheriyath, Tarek M Mekhail, et al.
Gynecologic Oncology|January 31, 2006
Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literatureMehdi M Kebria, Jerome Belinson, Robert Kim, et al.
The American Journal of Case Reports|July 18, 2017
Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case ReportCai Yuan, Muchou J Ma, John V Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinomaTarek M Mekhail, Rony M Abou-Jawde, Gabriel Boumerhi, et al.
Urologic Oncology|December 25, 2003
Renal cell carcinoma (RCC) and telomerase activity: relationship to stageTarek M Mekhail, Rika Kawanishi-Tabata, Raymond Tubbs, et al.
Cancer Investigation|August 2, 2017
First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)David R Spigel, Tarek M Mekhail, David Waterhouse, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohortGregory M M Videtic, Thomas W Rice, Sudish Murthy, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gynecologic Oncology|January 29, 2002
Acanthosis nigricans with endometrial carcinoma: case report and review of the literatureTarek M Mekhail, Maurie Markman
Expert Opinion on Pharmacotherapy|May 31, 2002
Paclitaxel in cancer therapyTarek M Mekhail, Maurie Markman
Current Oncology Reports|March 2, 2006
Phenoxodiol: isoflavone analog with antineoplastic activityToni K Choueiri, Robert Wesolowski, Tarek M Mekhail
Molecular Cancer Therapeutics|August 5, 2010
Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expressionWioleta Luszczek, Venugopalan Cheriyath, Tarek M Mekhail, et al.
Gynecologic Oncology|January 31, 2006
Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literatureMehdi M Kebria, Jerome Belinson, Robert Kim, et al.
The American Journal of Case Reports|July 18, 2017
Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case ReportCai Yuan, Muchou J Ma, John V Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinomaTarek M Mekhail, Rony M Abou-Jawde, Gabriel Boumerhi, et al.
Urologic Oncology|December 25, 2003
Renal cell carcinoma (RCC) and telomerase activity: relationship to stageTarek M Mekhail, Rika Kawanishi-Tabata, Raymond Tubbs, et al.
Cancer Investigation|August 2, 2017
First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)David R Spigel, Tarek M Mekhail, David Waterhouse, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: insights for radiotherapy planning from a surgical cohortGregory M M Videtic, Thomas W Rice, Sudish Murthy, et al.
Pageof 2